Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | +7.17% | +69.60% | +1.63% |
Apr. 30 | Top Midday Gainers | MT |
Apr. 30 | Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of FOMC Meeting | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.63% | 3.49M | |
-1.90% | 104B | |
+2.82% | 97.47B | |
+4.95% | 22.25B | |
-13.88% | 21.68B | |
-9.56% | 18.2B | |
-39.98% | 17.02B | |
-9.72% | 16.36B | |
+7.96% | 14.39B | |
+41.05% | 12.37B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Oppenheimer Adjusts Cyclacel Pharmaceuticals Price Target to $10 From $17, Maintains Outperform Rating